Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Filing content

The company received notification from Nasdaq confirming it has regained compliance with the $1.00 minimum bid price requirement after maintaining a closing bid price of at least $1.00 for 19 consecutive business days.